The Israeli Antitrust Authority has reportedly contacted Electra Consumer Products and Gil Sharon, who is responsible on the latter’s behalf for the ILS 350 million acquisition of Golan Telecom, Globes reported, citing sources. The authority is demanding to see e-mail correspondence between Electra Consumer and Sharon. No investigation is involved yet, and the authority has not summoned anyone to answer questions.
The sources added that the authority will confine its demand for e-mails to the acquisition deal and specific dates. Electra Consumer and Sharon have been required to deliver only material relevant to the Golan Telecom acquisition, not their entire mailbox.
This follows a Globes report that the acquisition was being delayed because of a Gil Sharon interview on Galei Tzahal (Army Radio) in January following the acquisition deal, which raised concern about coordination of prices. The Antitrust Authority did not like the interview and asked for a great deal of information about the deal. Globes says it has now emerged that the probe is focusing not only on Sharon, but also on Electra Consumer, on whose behalf he led the deal. Sharon is due to become active chairman of Golan Telecom once the acquisition is completed.
Full Content: Telecom Paper
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas